☆ 4.7 Article

Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes

VACCINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, General & Internal

Acute Respiratory Distress Syndrome 2022 2 Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management

Ellen A. Gorman et al.

Summary: This paper reviews the diagnosis, management, outcomes, and long-term sequelae of ARDS, discussing potential limitations of its definition and evidence for future revisions. It also explores guideline recommendations and uncertainties in ARDS management, as well as the future of ARDS in the context of precision medicine and treatable traits.

LANCET (2022)

添加到收藏夹

Review Pathology

Immunopathology of Hyperinflammation in COVID-19

Joshua N. Gustine et al.

Summary: The rapid spread of COVID-19 has led to an unprecedented global public health crisis with recent studies suggesting that the hyperinflammatory syndrome induced by SARS-CoV-2 is a contributing factor to disease severity and mortality. Pathophysiological research shows that the hyperinflammatory syndrome in severe COVID-19 results from a dysregulated innate immune response. Current potential therapeutic approaches are being investigated to modulate the immune response and mitigate lung injury in severe COVID-19.

AMERICAN JOURNAL OF PATHOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran et al.

Summary: Severe cases of COVID-19 show increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high antibody levels. High neutralization potency is a predictor of survival. Patient sera can neutralize different strains, indicating cross-protection from reinfection.

CELL (2021)

添加到收藏夹

Article Immunology

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

Vincent Legros et al.

Summary: The study investigated the neutralizing antibody response in serum samples from 140 confirmed SARS-CoV-2 infections, finding that antibody titers correlated with disease severity and anti-spike IgG levels. Post-recovery, patients' nAb activity declined more rapidly compared to individuals infected with other coronaviruses, and previous infection by human coronaviruses did not generate protective nAbs against SARS-CoV-2. Additionally, the D614G mutation in the spike protein did not lead to neutralization escape.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Humoral immune mechanisms involved in protective and pathological immunity during COVID-19 (Publication with Expression of Concern. See vol. 84, pg. 355, 2023)

Gunawan Widjaja et al.

Summary: SARS-CoV-2 associated with COVID-19 causes excessive inflammation, which correlates with severe conditions and death. Increased inflammatory cytokines and humoral response are key factors in COVID-19 immunity and pathogenesis, presenting as part of sepsis and hemophagocytic syndromes. Identifying hemophagocytic lymphohistiocytosis (HLH) from sepsis is crucial for determining appropriate treatment options.

HUMAN IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

Chandima Jeewandara et al.

Summary: This study found that the levels of NAbs in COVID-19 patients were associated with disease severity and duration of viral shedding. Lower levels of NAbs were seen in patients with mild illness, and these antibodies may decline during the recovery period.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Editorial Material Microbiology

The great escape? SARS-CoV-2 variants evading neutralizing responses

Jeremie Prevost et al.

Summary: The articles highlight the importance of surveillance of SARS-CoV-2 evolution to anticipate and manage new variants that could impact reinfection, vaccine efficacy, and immunotherapies.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Medicine, General & Internal

Understanding variants of SARS-CoV-2

Talha Burki

LANCET (2021)

添加到收藏夹

Article Virology

The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City

Alberto Cedro-Tanda et al.

Summary: The study reported the emergence of SARS-CoV-2 variant B.1.1.519 in Mexico City and analyzed its transmission characteristics, evolution process, and clinical impacts.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri et al.

Summary: The study reveals that antibody responses to SARS-CoV-2 spike protein play a significant role in neutralization and protection against severe COVID-19, unaffected by heterologous boosting or common cold immunity, and can last for up to 8 months.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Virology

Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico

Abril Paulina Rodriguez-Maldonado et al.

Summary: SARS-CoV-2 variants of concern, including the B.1.1.519 lineage in Mexico with mutations T478K, P681H, and T732A in the spike protein, have emerged and rapidly become dominant in the country during the first trimester of 2021.

ARCHIVES OF VIROLOGY (2021)

添加到收藏夹

Review Genetics & Heredity

The biological and clinical significance of emerging SARS-CoV-2 variants

Kaiming Tao et al.

Summary: The emergence of multiple SARS-CoV-2 variants has significant impacts on the epidemiological and clinical aspects of the COVID-19 pandemic, including increased virus transmission rates, heightened risk of reinfection, and reduced effectiveness of neutralizing antibodies and vaccines. These variants have introduced new challenges to COVID-19 research, necessitating additional avenues of laboratory, epidemiological, and clinical studies.

NATURE REVIEWS GENETICS (2021)

添加到收藏夹

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 variants of concern partially escape humoral but not T- cell responses in COVID-19 convalescent donors and vaccinees

Daryl Geers et al.

Summary: This study suggests that some variants might partially escape humoral immunity induced by SARS-CoV-2 infection or BNT162b2 vaccination, but the S-specific CD4(+) T-cell activation is not affected by the mutations in the B.1.1.7 and B.1.351 variants.

SCIENCE IMMUNOLOGY (2021)

添加到收藏夹

Letter Medical Laboratory Technology

Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study

Anna Schaffner et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

添加到收藏夹

Editorial Material Respiratory System

The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times

Martyn A. French et al.

RESPIROLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Molecular immune pathogenesis and diagnosis of COVID-19

Xiaowei Li et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)

添加到收藏夹

Letter Critical Care Medicine

Serum antibody response in critically ill patients with COVID-19

Alban Longchamp et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Immunology

Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Ger Rijkers et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

添加到收藏夹

Correction Immunology

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (vol 41, pg 355, 2020)

Shibo Jiang et al.

TRENDS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Kinetics of viral load and antibody response in relation to COVID-19 severity

Yanqun Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Christopher O. Barnes et al.

NATURE (2020)

添加到收藏夹

Article Virology

RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients

Kirsten Alexandra Eberhardt et al.

VIRUSES-BASEL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

ACE2: the molecular doorway to SARS-CoV-2

Miriam Marlene Medina-Enriquez et al.

CELL AND BIOSCIENCE (2020)

添加到收藏夹

Article Immunology

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Roltgen et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Article Cell Biology

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

Mehul S. Suthar et al.

CELL REPORTS MEDICINE (2020)

添加到收藏夹

Article Immunology

Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression

Liang Shen et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Article Immunology

Erratum

IMMUNOLOGICAL REVIEWS (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.